Cancer Res 2000, 60: 3096–104 PubMed 13 Shimakura Y, Kawada H, A

Cancer Res 2000, 60: 3096–104.PubMed 13. Shimakura Y, Kawada H, Ando K, Sato T, Nakamura Y, Tsuji T, Kato S, Hotta T: Murine stem cell line HESS-5 maintains reconstituting ability of ex vivo generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood. Stem Cells 2000, 18: 183–9.CrossRefPubMed 14. Koller MR, S3I-201 chemical structure Oxender M, Jensen TC, Goltry KL, Smith AK: Direct contact between CD34+ lin-cells and stroma induces a soluble activity

that specifically increases primitive hematopoietic cell production. Exp Hematol 1999, 27: 734–41.CrossRefPubMed 15. Zhang X, Wang P, Cheng XH, Liu L, Peng XG, Wang QY, Kong PY, Liu H, Zhang y, Gao L, Zhong YM: Effects of leukemia bone marrow stem cells on resistance of co-cultured HL-60 to Idarubicin. J Exp Hematol 2004, 12: 163–5. (article in Chinese) 16. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M: Intera ctions Between Human Mesenchymal Stem Cells and Natural Killer Cells. Stem Cells 2006, 24: 74–85.CrossRefPubMed 17. Rasmusson I, Ringdén O, Sundberg B, Le Blanc K: Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003, 76: 1208–13.CrossRefPubMed 18. Granziero L, Circosta P, Scielzo C, Frisaldi E, Stella S, Geuna M, Giordano S, Ghia P, Caligaris-Cappio

F: CD100/plexin B1 interactions sustain proliferation and sur vival of normal and leukemia SIS3 CD5 + B lymphocyte. Blood 2003, 101: 1962–9.CrossRefPubMed 19. Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, Akiyama T, Kuroda H, Kawano Y, Kobune M, Kato J, Hirayama Y, Sakamaki S, Kohda K, Miyake K, Niitsu Y: Interaction between leukemic cell VLA-4 and stem fibronectin is a decisive factor check details for minimal residual disease of acute myelogenous leukemia. Nat Med 2003, 9: 1158–65.CrossRefPubMed 20. Paraguassú-Braga

FH, Borojevic R, Bouzas LF, Barcinski MA, Bonomo A: Bone marrow stem inhibits proliferation and apoptosis in leukemic cells through gap junction mediated cell communication. Cell Death Differ 2003, 10: 1101–8.CrossRefPubMed 21. Cheng ZY, Guo XL, Yang XY, Niu ZY, Li SH, Wang SY, Chen H, Pan L: PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway. Journal of Experimental & Clinical Cancer Research 2008, 27: 87.CrossRef 22. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery. Cell 1997, 91: 231–41.CrossRefPubMed 23. Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phospha-tidylin ositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY 294002). J Biol Chem 1994, 269: 5241–8.PubMed Competing interests The authors declare that they have no competing interests.

Related posts:

  1. Int J Radiat Biol 2000, 76: 1297–1303 CrossRefPubMed 8 Courdi A,
  2. Note that the CHOC6 specimen did not respond to MLN0128 when trea
  3. Cancer Genet Cytogenet 2003, 140: 145–152 CrossRefPubMed 10 Cher
  4. BJU Int 2007, 99: 1223–1229 CrossRefPubMed 16 Jones TD, Eble JN,
  5. 2000] Moreover, age-related bone loss is directly correlated wit
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>